Phenotype and secretory responses to oxidative stress in Microglia

Developmental Neuroscience

Volumn 35, Issue 2-3, 2013, Pages 241-254

  Pathipati, Praneeti ^a   Müller, Sebastian ^b   Jiang, Xiangning ^a   Ferriero, Donna ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antioxidants; Cytokines; Development; Hydrogen peroxide; Inflammatory mediators; Neuroinflammation; Nitric oxide; Reactive oxygen species

Indexed keywords

HYDROGEN PEROXIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; CATALASE; FREE RADICAL; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE OXIDASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN INJURY; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RESPONSE; MICROGLIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING; BRAIN DEVELOPMENT; CELL HYPOXIA; CELL VIABILITY; CYTOKINE RELEASE; ENZYME ACTIVITY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MICROGLIAL CELL CULTURE; MONOCYTE; NEUROPROTECTION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; FLUORESCENT ANTIBODY TECHNIQUE; HYDROGEN PEROXIDE; MICE; MICE, INBRED C57BL; MICROGLIA; OXIDATIVE STRESS; PHENOTYPE; REACTIVE OXYGEN SPECIES;

EID: 84880246555     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000346159     Document Type: Conference Paper

References (65)

1. Hagberg H, Gilland E, Bona E, Hanson LA, Hahin-Zoric M, Blennow M, et al.: Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996; 40: 603-609.
2. Hedtjarn M, Leverin A-L, Eriksson K, Blomgren K, Mallard C, Hagberg H: Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002; 22: 5910-5919.
3. David S, Kroner A: Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci 2011; 12: 388-399.
4. Li L, Lu J, Tay SSW, Moochhala SM, He BP: The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro. Brain Res 2007; 1159: 8-17.
5. Alvarez-Diaz A, Hilario E, de Cerio FG, Valls-i-Soler A, Alvarez-Diaz FJ: Gypoxic-ischemic injury in the immature brain - key vascu lar and cellular players. Neonatology 2007; 92: 227-235.
6. Ferriero DM: Oxidant mechanisms in neonatal hypoxia-ischemia. Dev Neurosci 2001; 23: 198-202.
7. Halliwell B: Reactive oxygen species and the central nervous system. J Neurochem 1992; 59: 1609-1623.
8. Fullerton HJ, Diteberg JS, Chen SF, Sarco DP, Chan PH, Epstein CJ, Ferriero DM: Copper/zinc superoxide dismutase transgenic brain accumulates hydrogen peroxide after perinatal hypoxia ischemia. Ann Neurol 1998;44: 357-364.
9. Mischel RE, Kim YS, Sheldon RA, Ferriero DM: Gydrogen peroxide is selectively toxic to immature murine neurons in vitro. Neurosci Lett 1997; 231: 17-20.
10. Fan L-W, Pang Y, Lin S, Rhodes PG, Cai Z: Minocycline attenuates lipopolysaccharideinduced white matter injury in the neonatal rat brain. Neuroscience 2005; 133: 159-168.
11. Filipovic R, Zecevic N: Neuroprotective role of minocycline in co-cultures of human fetal neurons and microglia. Exp Neurol 2008; 211: 41-51.
12. Lechpammer M, Manning SM, Samonte F, Nelligan J, Sabo E, Talos DM, et al.: Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia. Neuropathol Appl Neurobiol 2008; 34: 379-393.
13. Arvin KL, Han BH, Du Y, Lin S, Paul SM, Holtzman DM: Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 2002; 52: 54-61.
14. Tsuji M, Wilson MA, Lange MS, Johnston MV: Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 2004; 189: 58-65.
15. Faustino JV, Wang X, Johnson CE, Klibanov A, Derugin N, Wendland MF, et al.: Microglial cells contribute to endogenous brain defenses after acute neonatal focal stroke. J Neurosci 2011; 31: 12992-13001.
16. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J: Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 2007; 27: 2596-2605.
17. Lafemina MJ, Sheldon RANN, Ferriero DM, L DNMJ, Pediatrics DMF, San C: Acute hypoxia-ischemia results in hydrogen peroxide accumulation in neonatal but not adult mouse brain. Pediatr Res 2006; 59: 680-683.
18. Mueller S, Arnhold J: Fast and sensitive chemiluminescence determination of H 2 O 2 concentration in stimulated human neutrophils. J Biolumin Chemilumin 1995; 10: 229-237.
19. Muller S: Sensitive and nonenzymatic measurement of hydrogen peroxide in biological systems; in Pryor WA (ed): Bio-Assays for Oxidative Stress Status (BOSS). New York, Elsevier, 2001, pp 170-175.
20. Gulden M, Jess A, Kammann J, Maser E, Seibert H: Cytotoxic potency of H 2 O 2 in cell cultures: Impact of cell concentration and exposure time. Free Radic Biol Med 2010; 49: 1298-1305.
21. Mueller S, Millonig G, Waite GN: The GOX/CAT system: A novel enzymatic method to independently control hydrogen peroxide and hypoxia in cell culture. Adv Med sci 2009; 54: 121-135.
22. Chang S, Jiang X, Zhao C, Lee C, Ferriero DM: Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons. Neurosc Lett 2008; 441: 134-138.
23. Millonig G, Hegedusch S, Becker L, Seitz H, Schuppan D, Mueller S: Gypoxia-inducible factor 1α under rapid enzymatic hypoxia: Cells sense decrements of oxygen but not hypoxia per se. Free Rad Biol Med 2009; 46: 182-191.
24. Dean JM, Wang X, Kaindl AM, Gressens P, Fleiss B, Hagberg H, et al.: Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-stimulated microglia in vitro. Brain Behav Immun 2010; 24: 776-783.
25. Rahman I, Kode A, Biswas SK: Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 2006; 1: 3159-3165.
26. Mueller S, Weber A, Fritz R, Mutze S, Rost D, Walczak H, Bolkl A SW: Sensitive and real-time determination of H 2 O 2 release from intact peroxisomes. Biochem J 2001; 363: 483-491.
27. Streit WJ: Microglia as neuroprotective, immunocompetent cells of the CNS. Exp Neurol 2002; 139: 133-139.
28. Minghetti L, Levi G: Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide. Prog Neurobiol 1998; 54: 99-125.
29. Liu Y, Schubert DR: The specificity of neuroprotection by antioxidants. J Biomed Sci 2009; 16: 98.
30. LeBel CP, Ischiropoulos H, Bondy SC: Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992; 5: 227-231.
31. Robinson KM, Janes MS, Beckman JS: The selective detection of mitochondrial superoxide by live cell imaging. Nat Protoc 2008; 3: 941-947.
32. Hirrlinger J, Gutterer JM, Kussmaul L, Hamprecht B, Dringen R: Microglial cells in culture express a prominent glutathione system for the defense against reactive oxygen species. Dev Neurosci 2000; 22: 384-392.
33. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG: Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009; 29: 13435-13444.
34. Auffray C, Sieweke MH, Geissmann F: Blood monocytes: Development, heterogeneity, and relationship with dendritic cells. Ann Rev Immunol 2009; 27: 669-692.
35. Desagher S, Glowinski J, Premont J: Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 1996; 16: 2553-2562.
36. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, et al.: Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 1993; 16: 323-328.
37. Sankarapandi S, Zweier JL, Mukherjee G, Quinn MT, Huso DL: Measurement and characterization of superoxide generation in microglial cells: Evidence for an NADPH oxidase-dependent pathway. Arch Biochem Biophys 1998; 353: 312-321.
38. Ding M, St Pierre BA, Parkinson JF, Medberry P, Wong JL, Rogers NE, et al.: Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia. A kinetic analysis. J Biol Chem 1997; 272: 11327-11335.
39. Bal-Price A, Matthias A, Brown GC: Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. J Neurochem 2002; 80: 73-80.
40. Chatterjee S, Noack H, Possel H, Wolf G: Induction of nitric oxide synthesis lowers intracellular glutathione in microglia of primary glial cultures. Glia 2000; 29: 98-101.
41. Dringen R: Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal 2005; 7: 1223-1233.
42. Brown GC, Neher JJ: Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. J Neurosci Res 2010; 41: 242-247.
43. Simi A, Tsakiri N, Wang P, Rothwell NJ: Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans 2007; 35: 1122-1126.
44. McCoy MK, Tansey MG: TNF signaling inhibition in the CNS: Implications for normal brain function and neurodegenerative disease. J Neuroinflammation 2008; 5: 45.
45. Raivich G, Jones LL, Werner A, Bluthmann H, Doetschmann T, Kreutzberg GW: Molecular signals for glial activation: Pro- and antiinflammatory cytokines in the injured brain. Acta Neurochir Suppl 1999; 73: 21-30.
46. Rothwell N, Allan S, Toulmond S: The role of interleukin 1 in acute neurodegeneration and stroke: Pathophysiological and therapeutic implications. J Clin Invest 1997; 100: 2648-2652.
47. Suzumura A: Immune response in the brain: Glial response and cytokine production; in Phelps C, Korneva E (eds): Cytokines and the Brain. Amsterdam, Elsevier, 2008, pp 289-303.
48. Olah M, Biber K, Vinet J, Boddeke HWGM: Microglia phenotype diversity. CNS Neurol Disord Drug Targets 2011; 10: 108-118.
49. Terao S, Yilmaz G, Stokes KY, Russell J, Ishikawa M, Kawase T, et al.: Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion. Stroke 2008; 39: 2560-2570.
50. Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV: Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J Cereb Blood Flow Metab 2006; 26: 797-810.
51. Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV: Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 2007; 38: 1345-1353.
52. Ivacko J, Szaflarski J, Malinak C, Flory C, Warren JS, Silverstein FS: Gypoxic-ischemic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain. J Cereb Blood Flow Metab 1997; 17: 759-770.
53. Belmadani A, Tran PB, Ren D, Miller RJ: Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci 2006; 26: 3182-3191.
54. Hinojosa AE, Garcia-Bueno B, Leza JC, Madrigal JLM: CCL2/MCP-1 modulation of microglial activation and proliferation. J Neuroinflammation 2011; 8: 77.
55. Bartolini A, Vigliani M-C, Magrassi L, Vercelli A, Rossi F: G-CSF administration to adult mice stimulates the proliferation of microglia but does not modify the outcome of ischemic injury. Neurobiol Dis 2011; 41: 640-649.
56. Bruno V, Copani A, Besong G, Scoto G, Nicoletti F: Neuroprotective activity of chemokines against N-methyl- D -aspartate or betaamyloid-induced toxicity in culture. Eur J Pharmacol 2000; 399: 117-121.
57. Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW: MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 2003; 85: 1299-1311.
58. Chiu K, Yeung S-C, So K-F, Chang RC-C: Modulation of morphological changes of microglia and neuroprotection by monocyte chemoattractant protein-1 in experimental glaucoma. Cell Mol Immunol 2010; 7: 61-68.
59. Yamasaki R, Tanaka M, Fukunaga M, Tateishi T, Kikuchi H, Motomura K, et al.: Restoration of microglial function by granulocytecolony stimulating factor in ALS model mice. J Neuroimmunol 2010; 229: 51-62.
60. Esen N, Kielian T: Effects of low dose GMCSF on microglial inflammatory profiles to diverse pathogen-associated molecular patterns (PAMPs). J Neuroinflammation 2007; 4: 10.
61. Suzumura A, Takeuchi H, Zhang G, Kuno R, Mizuno T: Roles of glia-derived cytokines on neuronal degeneration and regeneration. Ann NY Acad Sci 2006; 1088: 219-229.
62. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, et al.: Macrophage polarization in tumour progression. Seminars Cancer Biol 2008; 18: 349-355.
63. Martinez FO, Helming L, Gordon S: Alternative activation of macrophages: An immunologic functional perspective. Ann Rev Immunol 2009; 27: 451-483.
64. Suzumura A, Sawada M, Itoh Y, Marunouchi T: Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. J Neuroimmunol 1994; 53: 209-218.
65. Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. 2012. http://www.abd.or.kr/htm/jin/26.pdf.